CONA
AMPH icon

Capital One National Association’s Amphastar Pharmaceuticals AMPH Stock Holding History

Capital One National Association’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,895
Closed -$229K – 509
2017
Q4 		$229K Sell
11,895
-485
-4% -$9.06K 0.02% 482
2017
Q3 		$221K Buy
+12,380
New +$204K 0.02% 490

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital One National Association's AMPH Position: Q1 2018 in Review

Capital One National Association sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2018, closing a stake of 11,895 shares — an estimated $229K sold.

Capital One National Association first reported a position in AMPH in Q3 2017 and held it in 2 quarters. The position peaked at $229K in Q4 2017. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2018.

  • Capital One National Association reported no remaining Amphastar Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Capital One National Association sold 11,895 Amphastar Pharmaceuticals shares in Q1 2018, an estimated $229K.
  • Capital One National Association first reported a position in Amphastar Pharmaceuticals in Q3 2017 and held it in 2 quarters.
  • Capital One National Association's Amphastar Pharmaceuticals position peaked at $229K in Q4 2017.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2018.

Based on Capital One National Association's 13F filing for Q1 2018, filed 23 Apr 2018.